Detalhe da pesquisa
1.
Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
JAMA
; 316(17): 1808-1817, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802546
2.
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
JCI Insight
; 4(19)2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578311